Cargando…

Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice

Methamphetamine (METH) is a substance of abuse that causes dysregulation of the innate and adaptive immunity in users. B cells are involved in the humoral component of the adaptive immunity by producing and secreting antibodies (Abs). METH modifies Ab production, although limited information on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitha, Anum N., Chow, Daniela, Vaval, Valerie, Guerrero, Paulina, Rivera-Rodriguez, Dormarie E., Martinez, Luis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186300/
https://www.ncbi.nlm.nih.gov/pubmed/34109323
http://dx.doi.org/10.3389/ftox.2021.629451
_version_ 1783704926981980160
author Mitha, Anum N.
Chow, Daniela
Vaval, Valerie
Guerrero, Paulina
Rivera-Rodriguez, Dormarie E.
Martinez, Luis R.
author_facet Mitha, Anum N.
Chow, Daniela
Vaval, Valerie
Guerrero, Paulina
Rivera-Rodriguez, Dormarie E.
Martinez, Luis R.
author_sort Mitha, Anum N.
collection PubMed
description Methamphetamine (METH) is a substance of abuse that causes dysregulation of the innate and adaptive immunity in users. B cells are involved in the humoral component of the adaptive immunity by producing and secreting antibodies (Abs). METH modifies Ab production, although limited information on the impact of this psychostimulant on antigen (Ag)-specific humoral immune responses is available. Since T cell-dependent and T cell-independent Ags are involved in the activation of B lymphocytes, we explored the role of METH on humoral immunity to ovalbumin (OVA; T cell-dependent) and bacterial lipopolysaccharide (LPS; T cell-independent) in C57BL/6 mice. We demonstrated that METH extends the infiltration of B cells into pulmonary and splenic tissues 7 days post-Ag challenge. METH impairs Ab responses in the blood of animals challenged with OVA and LPS. Furthermore, METH diminishes the expression and distribution of IgM on B cell surface, suggesting a possible detrimental impact on users' humoral immunity to infection or autoimmunity.
format Online
Article
Text
id pubmed-8186300
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81863002021-06-08 Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice Mitha, Anum N. Chow, Daniela Vaval, Valerie Guerrero, Paulina Rivera-Rodriguez, Dormarie E. Martinez, Luis R. Front Toxicol Toxicology Methamphetamine (METH) is a substance of abuse that causes dysregulation of the innate and adaptive immunity in users. B cells are involved in the humoral component of the adaptive immunity by producing and secreting antibodies (Abs). METH modifies Ab production, although limited information on the impact of this psychostimulant on antigen (Ag)-specific humoral immune responses is available. Since T cell-dependent and T cell-independent Ags are involved in the activation of B lymphocytes, we explored the role of METH on humoral immunity to ovalbumin (OVA; T cell-dependent) and bacterial lipopolysaccharide (LPS; T cell-independent) in C57BL/6 mice. We demonstrated that METH extends the infiltration of B cells into pulmonary and splenic tissues 7 days post-Ag challenge. METH impairs Ab responses in the blood of animals challenged with OVA and LPS. Furthermore, METH diminishes the expression and distribution of IgM on B cell surface, suggesting a possible detrimental impact on users' humoral immunity to infection or autoimmunity. Frontiers Media S.A. 2021-03-15 /pmc/articles/PMC8186300/ /pubmed/34109323 http://dx.doi.org/10.3389/ftox.2021.629451 Text en Copyright © 2021 Mitha, Chow, Vaval, Guerrero, Rivera-Rodriguez and Martinez. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Toxicology
Mitha, Anum N.
Chow, Daniela
Vaval, Valerie
Guerrero, Paulina
Rivera-Rodriguez, Dormarie E.
Martinez, Luis R.
Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice
title Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice
title_full Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice
title_fullStr Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice
title_full_unstemmed Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice
title_short Methamphetamine Compromises the Adaptive B Cell-Mediated Immunity to Antigenic Challenge in C57BL/6 Mice
title_sort methamphetamine compromises the adaptive b cell-mediated immunity to antigenic challenge in c57bl/6 mice
topic Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186300/
https://www.ncbi.nlm.nih.gov/pubmed/34109323
http://dx.doi.org/10.3389/ftox.2021.629451
work_keys_str_mv AT mithaanumn methamphetaminecompromisestheadaptivebcellmediatedimmunitytoantigenicchallengeinc57bl6mice
AT chowdaniela methamphetaminecompromisestheadaptivebcellmediatedimmunitytoantigenicchallengeinc57bl6mice
AT vavalvalerie methamphetaminecompromisestheadaptivebcellmediatedimmunitytoantigenicchallengeinc57bl6mice
AT guerreropaulina methamphetaminecompromisestheadaptivebcellmediatedimmunitytoantigenicchallengeinc57bl6mice
AT riverarodriguezdormariee methamphetaminecompromisestheadaptivebcellmediatedimmunitytoantigenicchallengeinc57bl6mice
AT martinezluisr methamphetaminecompromisestheadaptivebcellmediatedimmunitytoantigenicchallengeinc57bl6mice